Product Information
MINTOX MAXIMUM STRENGTH SUSP is a generic product labeled by Major Pharmaceuticals, priced at $0.0121 per ML under NDC 00904572514. Its NADAC has been published 671 times since Nov 28, 2013.
Strength
400; 40; 400 mg/5mL; mg/5mL; mg/5mL
Manufacturer
Major PharmaceuticalsNDC
00904572514
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ALUMINUM HYDROXIDE; DIMETHICONE; MAGNESIUM HYDROXIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M001On Market Since
2/1/2011
Pharmacological Classes
Price Statistics
The NADAC for MINTOX MAXIMUM STRENGTH SUSP has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 70.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0121 per ML |
|---|---|
| All-time high | $0.0122 (Nov 13, 2024) |
| All-time low | $0.0067 (Dec 18, 2013) |
| 52-week high | $0.0121 |
| 52-week low | $0.0117 |
| Median price | $0.0078 |
| Average price | $0.0089 |
| Largest weekly change | +16.3% (Oct 20, 2021) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
aluminum hydroxide, magnesium hydroxide, dimethicone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Calculi Dissolution Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MINTOX MAXIMUM STRENGTH SUSP?
The current National Average Drug Acquisition Cost (NADAC) for MINTOX MAXIMUM STRENGTH SUSP, manufactured by Major Pharmaceuticals, is $0.0121 per ML (NDC 00904572514), effective Sep 30, 2026.
How has the price of MINTOX MAXIMUM STRENGTH SUSP changed over time?
Over the history we have for it, the NADAC for MINTOX MAXIMUM STRENGTH SUSP has risen 70.1%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MINTOX MAXIMUM STRENGTH SUSP?
Since Nov 28, 2013, the NADAC for MINTOX MAXIMUM STRENGTH SUSP has ranged from a low of $0.0067 (Dec 18, 2013) to a high of $0.0122 (Nov 13, 2024), with a median of $0.0078 per ML.
Are there cheaper alternatives to MINTOX MAXIMUM STRENGTH SUSP?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ANTACID-ANTIGAS LIQUID, is $0.0105 per ML — about 13% below MINTOX MAXIMUM STRENGTH SUSP.
Who manufactures MINTOX MAXIMUM STRENGTH SUSP?
MINTOX MAXIMUM STRENGTH SUSP (NDC 00904572514) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.